KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Depreciation & Amortization (IS)EBIATLeasesLong-Term Debt RepaymentsOther Gross PP&E AdjustmentsShares IssuedShares OutstandingShares Repurchased
Ratios

GoodRx Holdings (GDRX) Long-Term Debt Repayments (2019 - 2025)

Historic Long-Term Debt Repayments for GoodRx Holdings (GDRX) over the last 7 years, with Q3 2025 value amounting to $1.2 million.

  • GoodRx Holdings' Long-Term Debt Repayments fell 9980.28% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year decrease of 9941.32%. This contributed to the annual value of $639.0 million for FY2024, which is 1202365.77% up from last year.
  • According to the latest figures from Q3 2025, GoodRx Holdings' Long-Term Debt Repayments is $1.2 million, which was down 9980.28% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, GoodRx Holdings' Long-Term Debt Repayments ranged from a high of $633.8 million in Q3 2024 and a low of -$1000.0 during Q4 2023
  • Over the past 5 years, GoodRx Holdings' median Long-Term Debt Repayments value was $1.8 million (recorded in 2021), while the average stood at $36.8 million.
  • Per our database at Business Quant, GoodRx Holdings' Long-Term Debt Repayments crashed by 10005.69% in 2023 and then soared by 3597085.94% in 2024.
  • Over the past 5 years, GoodRx Holdings' Long-Term Debt Repayments (Quarter) stood at $1.8 million in 2021, then changed by 0.0% to $1.8 million in 2022, then plummeted by 100.06% to -$1000.0 in 2023, then surged by 63376600.0% to $633.8 million in 2024, then crashed by 99.8% to $1.2 million in 2025.
  • Its Long-Term Debt Repayments stands at $1.2 million for Q3 2025, versus $1.2 million for Q2 2025 and $1.2 million for Q1 2025.